HomeBusinessHealthcareBiogen (BIIB) Soars Following Positive Alzheimer’s Drug Trial
Biogen (BIIB) Soars Following Positive Alzheimer’s Drug Trial

Biogen (BIIB) soars following a positive Alzheimer’s drug trial. George Tsilis discusses this, as BMO Capital, Baird, and Mizuho analysts upgraded BIIB. He also talks about the hurdles that BIIB is having to face including how they are closer to regulatory approval but do not have it yet. He then demonstrates an example trade using BIIB. The trade type is a put vertical and the direction is neutral to bullish. Tune in to find out more about the stock market today.

Trading 360

28 Sep 2022

ON AIR
12:00 am
Fast Market
replay
ON AIR
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US